- We expect to be able to treat the first patients after summer and thus present interim data from the first dosage group with three patients at the turn of the year 2024/2025, says CEO
Read the article at biostock.se:
https://www.biostock.se/en/2024/05/eliceras-first-clinical-car-t-cell-study-carma-set-to-begin/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
https://news.cision.com/elicera-therapeutics/r/biostock-elicera-s-first-clinical-car-t-cell-study-carma-set-to-begin,c3990564
(c) 2024 Cision. All rights reserved., source